LLY,IFF Stock Price and Quote

Dollar change +16.80
Percentage change 2.45	%

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO VUG IVV SPY XLV VIG IWF VHT QUAL

Index	S&P 500	P/E	46.50	EPS (ttm)	15.08	Insider Own	10.34%	Shs Outstand	946.83M	Perf Week	12.08%
Market Cap	663.68B	Forward P/E	23.21	EPS next Y	30.21	Insider Trans	-0.92%	Shs Float	848.62M	Perf Month	-7.91%
Enterprise Value	700.12B	PEG	1.12	EPS next Q	6.31	Inst Own	73.59%	Short Float	0.85%	Perf Quarter	-4.37%
Income	13.80B	P/S	12.46	EPS this Y	74.59%	Inst Trans	-0.40%	Short Ratio	1.67	Perf Half Y	-19.57%
Sales	53.26B	P/B	36.34	EPS next Y	33.20%	ROA	15.97%	Short Interest	7.17M	Perf YTD	-9.17%
Book/sh	19.30	P/C	187.16	EPS next 5Y	41.57%	ROE	86.70%	52W High	972.53 -27.90%	Perf Year	-22.78%
Cash/sh	3.75	P/FCF	135.86	EPS past 3/5Y	24.14% 18.77%	ROIC	26.31%	52W Low	623.78 12.42%	Perf 3Y	130.21%
Dividend Est.	6.20 (0.88%)	EV/EBITDA	28.77	Sales past 3/5Y	16.73% 15.08%	Gross Margin	82.64%	Volatility	3.52% 3.06%	Perf 5Y	358.32%
Dividend TTM	5.60 (0.80%)	EV/Sales	13.15	EPS Y/Y TTM	88.21%	Oper. Margin	42.13%	ATR (14)	27.22	Perf 10Y	752.35%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.00	Sales Y/Y TTM	36.83%	Profit Margin	25.91%	RSI (14)	44.43	Recom	1.58
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.28	EPS Q/Q	91.71%	SMA20	-4.32%	Beta	0.46	Target Price	908.68
Payout	44.39%	Debt/Eq	2.18	Sales Q/Q	37.64%	SMA50	-8.22%	Rel Volume	1.89	Prev Close	684.43
Employees	47000	LT Debt/Eq	1.87	Earnings	Aug 07 BMO	SMA200	-11.62%	Avg Volume	4.29M	Price	701.23
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.70% 5.80%	Trades		Volume	8,115,587	Change	2.45%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375

Show Previous Ratings

Today 08:55AM	1 Beaten-Down Stock That Could Soar by the End of the Year (Motley Fool)
07:15AM	This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors (Motley Fool)
06:42AM	3 Fantastic Growth Stocks to Buy in August (Motley Fool)
02:13AM	JPMorgan Maintains 'Overweight' Rating on Eli Lilly and Company (LLY) With $1,100 PT (Insider Monkey)
12:54AM	Eli Lilly and Company (LLY) Releases Q2 2025 Results (Insider Monkey)
12:46PM	Loading…
Aug-16-25 12:46PM	Jim Cramer Says Don't Quit Market When It's Frothy: 'Is Widespread Irrationality a Reason To Sell Down in Perfectly Rational Stocks? Absolutely Not' (Benzinga)
08:45AM	Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet. (Motley Fool)
Aug-15-25 09:43PM	Cantor Fitzgerald Slashes PT on Eli Lilly and Company (LLY) to $825 From $975 (Insider Monkey)
05:31PM	Health Care Roundup: Market Talk (The Wall Street Journal)
03:16PM	Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst (Yahoo Finance)
02:55PM	Why Eli Lilly (LLY) Stock Is Up Today (StockStory)
01:54PM	Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst (Benzinga)
12:25PM	Novo Nordisk Stock Could Benefit From Eli Lilly's Weight-Loss Price Hikes (Barrons.com)
10:14AM	UK patients rush to buy obesity jab ahead of 170% price rise (Financial Times)
09:48AM	Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US (CNN Business)
09:20AM	Loading…
09:20AM	Veru Announces Novel Modified-Release Oral Formulation for Enobosarm (Zacks)
09:06AM	Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave? (Zacks)
08:48AM	Big Pharma Has a New Vision for Selling Drugs. It's Going to the Mattresses. (Barrons.com)
07:52AM	UK pharmacist says Eli Lillys Mounjaro price hike a shock (Pharmaceutical Technology)
06:40AM	Buffett Stock Buys Say Plenty About the Stock Market. Why His Inaction Says More. (Barrons.com)
06:02AM	S&P Futures Tick Higher With Focus on U.S. Retail Sales Data and Trump-Putin Meeting (Barchart)
06:02AM	S&P Futures Muted With Focus on U.S. Retail Sales Data and Trump-Putin Meeting (Barchart)
02:53AM	Jim Cramer Says He is "Very Upset" With Eli Lilly (Insider Monkey)
Aug-14-25 07:00PM	Eli Lilly raises price of diabetes drug Mounjaro in UK ahead of Trump deadline (CNBC TV)
05:20PM	Guidance Watch: 2 Companies Bullishly Raising Forecasts (Zacks)
04:12PM	Eli Lilly Hikes UK Mounjaro Price By Up To 170% As Trump Pressure Mounts (Investor's Business Daily)
03:54PM	Oracle, Eli Lilly, Terawulf: Trending Tickers (Yahoo Finance Video)
02:26PM	Eli Lilly Says It Will Raise European Prices of its Medicines as Trump Pushes for U.S. Price Cuts (Barrons.com)
02:20PM	Eli Lilly to Raise U.K. Price of Mounjaro for Out-of-Pocket Patients (The Wall Street Journal)
01:44PM	Eli Lilly and Company (LLY): "Wall Street Was Really Wrong," Says Jim Cramer (Insider Monkey)
01:31PM	Loading…
01:31PM	Eli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal (Pharmaceutical Technology)
12:21PM	C3.ai downgrade, OracleAlphabet deal, Eli Lilly & Superluminal (Yahoo Finance Video)
11:46AM	Top Stock Movers Now: Tapestry, Deere, Eli Lilly, and More (Investopedia)
11:23AM	Lanier Law Firm Representing Health Choice Alliance in Litigation Alleging Eli Lilly Offered Kickbacks to Texas Health Care Providers (Business Wire)
11:07AM	Lilly Raises UK Obesity Shot Price as Trump Pressures Pharma (Bloomberg)
09:00AM	Goodpath Adds Self-Pay GLP-1 Option Through Integration with LillyDirect Pharmacy Provider GiftHealth (PR Newswire)
08:35AM	Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics (Zacks)
08:32AM	Eli Lilly raises UK price of weight loss drug Mounjaro by up to 170% (Financial Times)
08:15AM	Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines (Reuters)
08:04AM	Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity (PR Newswire)
06:30AM	4 trends among retail investors according to Robinhood's CIO (Yahoo Finance Video)
02:00AM	Vanguard Health Care Fund's Strategic Moves: Johnson & Johnson Takes Center Stage with 2. ... (GuruFocus.com)
01:36AM	5 Must-Read Analyst Questions From Eli Lilly's Q2 Earnings Call (StockStory)
Aug-13-25 03:37PM	Jim Cramer on Eli Lilly Stock: "It Just Got Pole-Axed, Laid to Waste" (Insider Monkey)
03:20PM	Why Eli Lilly Stock Popped Today (Motley Fool)
03:11PM	Eli Lilly First to Use Germany's New Confidential Pricing for Mounjaro (Insider Monkey)
03:01PM	Eli Lilly (LLY) Stock Trades Up, Here Is Why (StockStory)
02:30PM	Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst (Benzinga)
02:16PM	3 Unusual Insider Transactions you Should Know About (Zacks)
01:48PM	Eli Lilly Fires Up GLP-1 Race in India With Mounjaro Pen Launch (GuruFocus.com)
12:17PM	Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks? (Zacks)
11:30AM	Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs (Pharmaceutical Technology)
10:55AM	LLY: Eli Lilly Stock Tanks -- Insiders Rush In With Millions (GuruFocus.com)
10:47AM	Novo Nordisk Rises 6% So Far in August: How to Play the Stock (Zacks)
09:33AM	Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB (GlobeNewswire)
08:15AM	Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound (Benzinga)
04:10AM	The 3 Things That Matter for Viking Therapeutics Now (Motley Fool)
03:40AM	Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry (Reuters)
Aug-12-25 07:08PM	Analyst Report: Incyte Corporation (Morningstar Research)
07:07PM	These Eli Lilly executives have been scooping up stock after its big drop (MarketWatch)
06:15PM	Lilly CEO Buys $1 Million of Stock After Share-Price Drop on Obesity Drug Data (Barrons.com)
01:37PM	Eli Lilly and GSK drive South Koreas drug licensing activity (Pharmaceutical Technology)
01:24PM	Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications (Reuters)
11:10AM	The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly (Zacks)
09:45AM	1 Reason to Buy Eli Lilly (LLY) Stock (Motley Fool)
07:59AM	If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today (Motley Fool)
05:32AM	US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche (GlobeNewswire)
03:26AM	LLY Q2 Deep Dive: Weight Loss Pill Data and Channel Dynamics Spur Investor Uncertainty (StockStory)
02:57AM	3 ways the GLP-1 market has changed shape this year (Pharma Voice)
02:57AM	Puerto Ricos ongoing journey from manufacturing hub to innovation enterprise (Pharma Voice)
Aug-11-25 08:49PM	Lightning Round: Get on board with Affirm, says Jim Cramer (CNBC TV)
08:18PM	Lilly's Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial (Insider Monkey)
06:01PM	PRIMECAP Management's Strategic Moves: Significant Reduction in Eli Lilly and Co (GuruFocus.com)
03:48PM	Why Eli Lilly Stock Popped Today (Motley Fool)
12:31PM	Why Eli Lilly (LLY) Stock Is Trading Up Today (StockStory)
12:25PM	Lilly first to opt for confidential reimbursement price in Germany (Pharmaceutical Technology)
11:57AM	3 Top Stocks to Load Up on After Earnings (Motley Fool)
10:23AM	Can Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval? (Zacks)
10:19AM	Eli Lilly (LLY) Announced Positive Results From its Phase 3 ATTAIN-1 Trial of Orforglipron (Insider Monkey)
09:15AM	Lilly (LLY) Reliance on International Sales: What Investors Need to Know (Zacks)
09:12AM	Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results? (Zacks)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:46AM	Leerink Downgrades Eli Lilly and Company (LLY) to Market Perform From Outperform (Insider Monkey)
Aug-10-25 04:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Aug-09-25 10:00AM	Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly (MarketBeat)
06:04AM	Apple notches best week in years; Trump shakes Fed leadership: This Week in markets (Detroit Free Press)
Aug-08-25 06:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
05:25PM	Why Eli Lilly Stock Sank 18% This Week (Motley Fool)
05:08PM	GLP-1 race heats up: Where Eli Lilly stands after weak trial data (Yahoo Finance Video)
04:52PM	Health Care Roundup: Market Talk (The Wall Street Journal)
02:34PM	Calls of the Day: Eli Lilly, E.L.F. Beauty and CRH PLC (CNBC TV)
02:28PM	Investing.coms stocks of the week (Investing.com)
01:30PM	This Unusually Active Wayfair Put Option Explains a Lot About the Current Markets (Barchart)
01:17PM	The Stock Market Gains Despite Noisy Week. Call It Complacency-or the Right Thing to Do. (Barrons.com)
12:19PM	Did Eli Lilly Stock Just Have Its Novo Nordisk Moment? (Barrons.com)
12:00PM	Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization (GlobeNewswire)
12:00PM	Is Eli Lilly's 14% Post-Earnings Slide a Buy-the-Dip Opportunity? (MarketBeat)
11:45AM	Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y (Zacks)
11:00AM	ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data (Zacks)
09:22AM	Stock Market News for Aug 8, 2025 (Zacks)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM

Dollar change +0.10
Percentage change 0.15	%

IFF International Flavors & Fragrances Inc daily Stock Chart

Peers: APD PPG DD ADM FMC DSM TSE ANDE FUTU RKT

| Held by: VTI VOO VO MOAT IVV SPY VTV XLB VOE RSP

Index	S&P 500	P/E	-	EPS (ttm)	-1.55	Insider Own	1.62%	Shs Outstand	256.30M	Perf Week	3.56%
Market Cap	16.87B	Forward P/E	14.58	EPS next Y	4.52	Insider Trans	2.63%	Shs Float	252.13M	Perf Month	-12.28%
Enterprise Value	22.93B	PEG	-	EPS next Q	1.02	Inst Own	94.86%	Short Float	2.11%	Perf Quarter	-13.54%
Income	-393.00M	P/S	1.49	EPS this Y	-1.43%	Inst Trans	0.31%	Short Ratio	2.87	Perf Half Y	-23.47%
Sales	11.30B	P/B	1.17	EPS next Y	6.30%	ROA	-1.41%	Short Interest	5.32M	Perf YTD	-22.15%
Book/sh	56.20	P/C	20.67	EPS next 5Y	5.13%	ROE	-2.74%	52W High	106.77 -38.35%	Perf Year	-31.87%
Cash/sh	3.18	P/FCF	30.12	EPS past 3/5Y	-4.88% -24.99%	ROIC	-1.90%	52W Low	62.33 5.60%	Perf 3Y	-46.51%
Dividend Est.	1.64 (2.49%)	EV/EBITDA	10.66	Sales past 3/5Y	-0.49% 17.44%	Gross Margin	31.12%	Volatility	2.46% 2.86%	Perf 5Y	-49.58%
Dividend TTM	1.60 (2.43%)	EV/Sales	2.03	EPS Y/Y TTM	83.36%	Oper. Margin	10.07%	ATR (14)	1.97	Perf 10Y	-43.40%
Dividend Ex-Date	Sep 29, 2025	Quick Ratio	1.10	Sales Y/Y TTM	-0.07%	Profit Margin	-3.48%	RSI (14)	35.00	Recom	1.95
Dividend Gr. 3/5Y	-19.96% -11.58%	Current Ratio	1.85	EPS Q/Q	258.58%	SMA20	-6.39%	Beta	1.08	Target Price	81.61
Payout	168.56%	Debt/Eq	0.48	Sales Q/Q	-4.33%	SMA50	-10.49%	Rel Volume	0.75	Prev Close	65.72
Employees	22400	LT Debt/Eq	0.43	Earnings	Aug 05 AMC	SMA200	-18.11%	Avg Volume	1.86M	Price	65.82
IPO	Mar 02, 1964	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.56% 2.28%	Trades		Volume	1,389,064	Change	0.15%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-25	Downgrade	Oppenheimer	Outperform → Perform
Jun-04-25	Initiated	Tigress Financial	Buy	$105
May-08-25	Upgrade	Barclays	Equal Weight → Overweight	$84
Feb-20-25	Downgrade	CFRA	Buy → Sell	$77
Jan-07-25	Upgrade	Argus	Hold → Buy
Nov-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$111 → $110
Nov-08-24	Upgrade	BofA Securities	Neutral → Buy	$107
Nov-07-24	Upgrade	Vertical Research	Hold → Buy	$109
Sep-11-24	Reiterated	Oppenheimer	Outperform	$116 → $117
Sep-03-24	Upgrade	Mizuho	Neutral → Outperform	$109 → $120
Jul-22-24	Upgrade	Stifel	Hold → Buy	$95 → $115
Jun-07-24	Initiated	Oppenheimer	Outperform	$116
May-21-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$100
May-08-24	Upgrade	JP Morgan	Neutral → Overweight	$75 → $100
Apr-18-24	Upgrade	Barclays	Underweight → Equal Weight
Apr-10-24	Upgrade	Citigroup	Neutral → Buy	$81 → $100
Mar-08-24	Downgrade	Argus	Buy → Hold
Mar-01-24	Initiated	Wolfe Research	Underperform
Jan-22-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$81 → $90
Jan-12-24	Upgrade	Jefferies	Hold → Buy	$73 → $112

Show Previous Ratings

Aug-15-25 12:02PM	IFF Launches POWERFRESH ACE 2000 to Enhance Bread Sustainability (Zacks)
Aug-13-25 04:15PM	IFF to Webcast Fireside Chat at Barclays Global Consumer Staples Conference on Sept. 4 (Business Wire)
07:00AM	IFF Launches POWERFRESH ACE 2000, a Bread Fresh-Keeping Solution That Aces the Shelf-Life Test (Business Wire)
Aug-11-25 09:15AM	International Flavors (IFF) Reliance on International Sales: What Investors Need to Know (Zacks)
Aug-07-25 04:30AM	[Latest] Global Antioxidant BHT Market Size/Share Worth USD 542 Million by 2034 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:55PM	Loading…
Aug-06-25 12:55PM	International Flavors Q2 Earnings Beat Estimates, Sales Dip Y/Y (Zacks) -6.32%
11:02AM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Aug-05-25 06:00PM	International Flavors (IFF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	International Flavors (IFF) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:26PM	International Flavors: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	IFF Reports Second Quarter 2025 Results (Business Wire)
Aug-01-25 12:35PM	International Flavors to Report Q2 Earnings: Here's What to Expect (Zacks)
Jul-31-25 07:42PM	Materials Dividends Spotlight: International Flavors & Fragrances' (IFF) Consistent Payouts (Insider Monkey)
Jul-30-25 04:20PM	IFF Declares Dividend for Third Quarter 2025 (Business Wire)
04:15PM	IFF Appoints Paul J. Fribourg and Jesus B. Mantas to Board of Directors (Business Wire)
10:00AM	Loading…
Jul-29-25 10:00AM	Earnings Preview: International Flavors (IFF) Q2 Earnings Expected to Decline (Zacks)
Jul-24-25 06:00AM	IFF Introduces ENVIROCAP, a Breakthrough Scent Delivery Technology for Fabric Care (Business Wire)
Jul-18-25 07:08AM	China Food Ingredients Market Company Analysis Report 2025-2034, Featuring Archer-Daniels-Midland, Cargill, BASF, Corbion, Kerry Group, DSM-Firmenich, International Flavors & Fragrances, and Palsgaard (GlobeNewswire)
Jul-17-25 06:47AM	International Flavors & Fragrances Inc. (IFF) Unveils CHOOZIT LIFT to Enhance Cheese Making. (Insider Monkey)
02:59AM	IFF Unveils Immersive Experience Hub in Singapore to Accelerate Customer Collaboration, Product Innovation (Insider Monkey)
Jul-16-25 01:53PM	$9 Billion Hidden Empire: The Billionaire Family Quietly Buying Up the Stock Market (GuruFocus.com)
12:07PM	International Flavors & Fragrances Earnings Preview: What to Expect (Barchart)
Jul-10-25 11:48AM	Tigress Financial Assigns International Flavors & Fragrances (IFF) a Buy Rating (Insider Monkey)
12:00AM	IFF Expands Innovation Center in Singapore with New Immersive Experience Hub (Business Wire)
Jul-09-25 04:15PM	IFF to Release Second Quarter 2025 Results on Aug. 5, 2025 (Business Wire)
Jul-02-25 04:15AM	Givaudan SA and International Flavors & Fragrances Inc. Lead the US$840 Million Citrus Bioflavonoids Industry (GlobeNewswire)
Jun-26-25 03:53PM	Siegfried welcomes Erik Fyrwald, recognized leader in innovation, to its Advisory Board (PR Newswire)
04:00AM	IFF Launches Transformational Culture to Drive Energy and Water Efficiency in Semi-Hard Cheese Production (Business Wire)
Jun-25-25 11:00AM	IFF's 2024 Do More Good Report Highlights Progress in Sustainability and Innovation (Business Wire)
Jun-24-25 03:13PM	International Flavors & Fragrances Inc. (IFF): A Bull Case Theory (Insider Monkey)
10:57AM	Loading…
10:57AM	International Flavors Opens Facility in Hyderabad With Focus on Innovation (Zacks)
Jun-23-25 06:00AM	IFF Opens New State-of-the-art Office in Hyderabad, India (Business Wire)
Jun-17-25 02:37PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Jun-11-25 11:30AM	UBS Maintains Neutral Rating on International Flavors & Fragrances Inc. (IFF), PT $83 (Insider Monkey)
Jun-09-25 05:46PM	IFF Appoints Virginia "Gina" Drosos to Board of Directors (Business Wire)
Jun-04-25 11:00AM	IFF Unveils Game-Changing Outlook on GLP-1 Consumers (Business Wire)
May-30-25 08:44AM	Implied Volatility Surging for International Flavors Stock Options (Zacks)
May-29-25 09:36AM	Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought (MarketBeat)
May-23-25 09:03AM	International Flavors Stock Sees Big Insider Buy (Barrons.com)
May-16-25 05:17PM	IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes (Business Wire)
06:30AM	IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes (Business Wire)
May-13-25 09:16AM	Investing in International Flavors (IFF)? Don't Miss Assessing Its International Revenue Trends (Zacks)
May-09-25 08:00AM	IFF Completes Divestiture of Nitrocellulose Business (Business Wire)
May-08-25 03:15AM	International Flavors & Fragrances Inc (IFF) Q1 2025 Earnings Call Highlights: Strong Start ... (GuruFocus.com)
12:10AM	Q1 2025 International Flavors & Fragrances Inc Earnings Call (Thomson Reuters StreetEvents)
May-07-25 05:19PM	S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments (Investopedia) -7.08%
12:13PM	International Flavors Q1 Earnings Beat Estimates, Sales Dip Y/Y (Zacks)
12:03PM	IFF targets $10.6B to $10.9B in 2025 sales amid strategic realignment (Seeking Alpha)
12:03PM	International Flavors & Fragrances Inc. (IFF) Q1 2025 Earnings Call Transcript (Seeking Alpha)
11:21AM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
May-06-25 06:00PM	Compared to Estimates, International Flavors (IFF) Q1 Earnings: A Look at Key Metrics (Zacks)
05:30PM	International Flavors (IFF) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:20PM	IFF Reports First Quarter 2025 Results (Business Wire)
May-02-25 10:56AM	Stagnating Growth, Merger Hangover, And Asset Impairments With International Flavors & Fragrances (Seeking Alpha)
09:10AM	IFF Announces Tender Offers for Certain Outstanding Series of Notes (Business Wire)
May-01-25 06:00PM	Quaker Chemical (KWR) Tops Q1 Earnings Estimates (Zacks)
04:15PM	IFF Declares Dividend for Second Quarter 2025 (Business Wire)
12:18PM	International Flavors Set to Report Q1 Earnings: What to Expect? (Zacks)
09:15AM	International Flavors (IFF) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
02:00AM	IFF Completes Divestiture of Pharma Solutions Business Unit (Business Wire)
Apr-29-25 10:01AM	International Flavors (IFF) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-28-25 05:00PM	IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025 (Business Wire)
08:00AM	IFF Expands Pet Portfolio with Latest Science-driven Solutions (Business Wire)
Apr-23-25 08:21PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Apr-22-25 02:00AM	IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods Europe 2025 (Business Wire)
Apr-16-25 08:54AM	Dodge & Cox International Stock Fund Q1 2025 Shareholder Letter (Seeking Alpha)
12:00AM	IFF Opens Dubai Creative Center With Perfumery Art Studio (Business Wire)
Apr-14-25 04:15PM	IFF to Release First Quarter 2025 Results on May 6, 2025 (Business Wire)
09:02AM	International Flavors to Boost Presence in Mexico With New Facility (Zacks)
Apr-10-25 09:11AM	Strength Seen in International Flavors (IFF): Can Its 9.2% Jump Turn into More Strength? (Zacks)
08:00AM	IFF Opens Mexico Business Hub at Tecnoparque (Business Wire)
Apr-09-25 08:00AM	IFF Unveils Cutting-Edge Citrus Innovation Center in Florida (Business Wire) +9.15%
Apr-08-25 07:23PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research) -5.46%
08:00AM	IFF Pharma Solutions Launches Low Nitrite METHOCEL HPMC for Nitrosamine Mitigation (Business Wire)
Apr-03-25 03:30PM	Material World: Spinnova Collaborator Forms Joint Venture With IFF (Sourcing Journal)
01:43PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Apr-01-25 03:00AM	IFF Introduces Science of Performance: A New Approach to Elevating Scent Design (Business Wire)
Mar-30-25 08:41AM	International Flavors & Fragrances Inc. (IFF): Among Blue Chip Stocks to Invest in at 52-Week Lows (Insider Monkey)
Mar-27-25 04:45PM	Is International Flavors & Fragrances (IFF) The Most Expensive Stock Insiders Are Buying In March? (InsiderMonkey)
02:00AM	IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale (Business Wire)
Mar-24-25 07:00PM	IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025 (Business Wire)
01:24PM	International Flavors Stock Dips 24% in 6 Months: Will It Bounce Back? (Zacks)
Mar-20-25 11:30AM	Why Is International Flavors (IFF) Down 1.8% Since Last Earnings Report? (Zacks)
Mar-10-25 08:00PM	IFF Extends Enviva® PRO Probiotic Range to Improve Swine Welfare (PR Newswire)
Mar-05-25 04:15PM	IFF Declares Dividend for First Quarter 2025 (Business Wire)
Mar-03-25 12:37AM	International Flavors & Fragrances (IFF): Among Top Stock Picks From Carl Icahns Portfolio (Insider Monkey)
Feb-27-25 02:54PM	Is International Flavors & Fragrances Inc. (IFF) the Best High Growth Chemical Stock to Buy? (Insider Monkey)
Feb-25-25 07:00AM	IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility (Business Wire)
Feb-21-25 05:22AM	IFF eyeing acquisitions again as it sells off pharma unitbut no more Frutaroms (Fortune)
Feb-20-25 05:11PM	IFF Unveils Shanghai Creative Center (WWD)
04:30PM	IFF Announces Executive Leadership Team Aligned With New Operating Model (Business Wire)
02:06AM	International Flavors & Fragrances Inc (IFF) Q4 2024 Earnings Call Highlights: Strong ... (GuruFocus.com)
01:06AM	Q4 2024 International Flavors & Fragrances Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 03:57PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research) -5.16%
Feb-18-25 06:00PM	International Flavors (IFF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	International Flavors (IFF) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:25PM	International Flavors: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	IFF Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-13-25 04:00PM	IFF Announces Launch of New IFF.com (PR Newswire)
09:15AM	Countdown to International Flavors (IFF) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FRIBOURG PAUL J	Director	Aug 07 '25	Buy	64.80	15,450	1,001,183	15,450	Aug 08 06:49 PM
Fyrwald J Erik	Chief Executive Officer	Aug 07 '25	Buy	64.95	15,300	993,714	77,370	Aug 07 06:59 PM
Teles de Mendonca Ana Paula	President, Scent	Jun 02 '25	Option Exercise	0.00	643	0	3,088	Jun 04 05:38 PM
Arora Yuvraj	President, Taste & CCO	May 05 '25	Option Exercise	0.00	17,309	0	22,291	Jun 04 05:27 PM
Arora Yuvraj	President, Taste & CCO	May 01 '25	Option Exercise	0.00	3,572	0	6,810	Jun 04 05:27 PM
O'Byrne Kevin	Director	May 22 '25	Buy	76.05	4,500	342,240	7,696	May 23 04:46 PM
Teles de Mendonca Ana Paula	President, Scent	May 05 '25	Option Exercise	0.00	1,498	0	3,210	May 22 07:30 PM
Teles de Mendonca Ana Paula	President, Scent	May 01 '25	Option Exercise	0.00	1,587	0	2,523	May 22 07:30 PM
Palau Hernandez Margarita	Director	May 19 '25	Buy	77.42	850	65,807	2,393	May 20 01:33 PM
Yildiz Beril	CAO, SVP & Controller	May 19 '25	Sale	77.33	2,400	185,604	3,321	May 19 05:09 PM
Landsman Stephen N	EVP, General Counsel	May 19 '25	Buy	77.28	12,000	927,356	12,000	May 19 05:08 PM
Yildiz Beril	Officer	May 19 '25	Proposed Sale	77.33	2,400	185,604		May 19 01:12 PM
Yildiz Beril	CAO, SVP & Controller	May 05 '25	Option Exercise	0.00	849	0	6,028	May 16 09:01 PM
Yildiz Beril	CAO, SVP & Controller	May 01 '25	Option Exercise	0.00	952	0	5,523	May 16 09:01 PM
Finzel Ralf	EVP, Global Operations Officer	May 05 '25	Option Exercise	0.00	1,326	0	9,976	May 16 09:01 PM
Finzel Ralf	EVP, Global Operations Officer	May 01 '25	Option Exercise	0.00	1,984	0	9,663	May 16 09:01 PM
DeVeau Michael	EVP, CFO	May 05 '25	Option Exercise	0.00	884	0	11,048	May 16 09:01 PM
DeVeau Michael	EVP, CFO	May 01 '25	Option Exercise	0.00	1,389	0	10,874	May 16 09:01 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	May 05 '25	Option Exercise	0.00	1,768	0	28,383	May 16 09:00 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	May 01 '25	Option Exercise	0.00	2,381	0	27,817	May 16 09:00 PM
Palau Hernandez Margarita	Director	May 01 '25	Option Exercise	0.00	1,543	0	1,543	May 16 08:57 PM
O'Byrne Kevin	Director	May 01 '25	Option Exercise	0.00	1,875	0	3,590	May 16 08:56 PM
Khan Mehmood	Director	May 15 '25	Buy	75.33	4,000	301,314	4,604	May 15 05:27 PM
Fyrwald J Erik	Chief Executive Officer	May 09 '25	Buy	73.97	24,300	1,797,456	62,070	May 09 05:03 PM
Fyrwald J Erik	Chief Executive Officer	May 08 '25	Buy	74.00	700	51,797	37,770	May 09 05:03 PM
JAMISON CYNTHIA T	Director	May 01 '25	Option Exercise	0.00	604	0	604	May 05 05:51 PM
INTRIERI VINCENT J	Director	May 01 '25	Option Exercise	0.00	604	0	604	May 05 05:50 PM
Costa Mark J	Director	May 01 '25	Option Exercise	0.00	1,875	0	4,014	May 05 05:50 PM
Khan Mehmood	Director	May 01 '25	Option Exercise	0.00	604	0	604	May 05 05:47 PM
Fyrwald J Erik	Chief Executive Officer	May 01 '25	Option Exercise	0.00	15,875	0	45,175	May 05 05:46 PM
Strzelecki Angela	President, Pharma Solutions	Apr 04 '25	Option Exercise	0.00	1,761	0	10,362	Apr 07 04:17 PM
DeVeau Michael	CFO	Apr 04 '25	Option Exercise	0.00	1,993	0	10,204	Apr 07 04:16 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	Apr 04 '25	Option Exercise	0.00	4,602	0	27,981	Apr 07 04:16 PM
O'Byrne Kevin	Director	Mar 05 '25	Buy	80.44	6,500	522,833	6,500	Mar 06 05:13 PM
Fyrwald J Erik	CEO	Mar 04 '25	Buy	80.24	25,000	2,005,878	29,300	Mar 05 04:08 PM
Finzel Ralf	EVP, Global Operations Officer	Dec 02 '24	Option Exercise	0.00	5,387	0	9,622	Dec 03 04:05 PM
Arora Yuvraj	President, Nourish	Nov 11 '24	Sale	91.75	5,000	458,775	3,238	Nov 12 04:20 PM
Arora Yuvraj	Officer	Nov 11 '24	Proposed Sale	91.75	5,000	458,775		Nov 12 09:07 AM
RICHTER GLENN R	CFO	Oct 01 '24	Option Exercise	0.00	11,812	0	32,171	Oct 03 04:20 PM
Borg Deborah	EVP, Chief HR and D&I Officer	Sep 03 '24	Option Exercise	0.00	13,807	0	30,282	Sep 05 04:05 PM

LLY

Lilly(Eli) & Co

IFF

International Flavors & Fragrances Inc

Upgrade your FINVIZ experience